Use of palivizumab and infection control measures to control an outbreak of respiratory syncytial virus in a neonatal intensive care unit confirmed by real-time polymerase chain reaction
Journal of Hospital Infection, 04/18/2011
O’Connell K et al. – Respiratory syncytial virus (RSV) A infection was confirmed by real–time polymerase chain reaction. Palivizumab was administered to all infants in the neonatal intensive care unit. There were no additional symptomatic cases and repeat RSV surveillance confirmed that there was no further cross–transmission within the unit. The outbreak highlighted the infection control challenge of very high bed occupancy in the unit and the usefulness of molecular methods in facilitating detection and management.